Journal
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Volume 129, Issue -, Pages 272-280Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.yjmcc.2019.03.010
Keywords
Epigenetics; RNA; Cardiovascular
Categories
Funding
- NIH [HL121284, HL136951, HL134616]
- American Heart Association (AHA) [17IRG33460198]
- United States Israel Binational Science Foundation (BSF) [2017094]
- European Research Council (ERC) Starting Grant MODVASC
Ask authors/readers for more resources
Cardiovascular disease (CVD) remains the leading cause of death in the Western world. Despite advances in the prevention and in the management of CVD, the role of RNA epigenetics in the cardiovascular system has been until recently unexplored. The rapidly expanding research field of RNA modifications has introduced a novel layer of gene regulation in mammalian cells. RNA modifications may control all aspects of RNA metabolism, and their study reveals previously unrecognized regulatory pathways that may determine gene expression at a post-transcriptional level. Understanding the role of RNA modifications in CVD may lead towards a better understanding of disease mechanisms and the development of novel biomarkers or therapeutic strategies. In this review, we highlight the most recent and major reports in the field of RNA methylation and adenosine to inosine RNA editing related to the cardiovascular field and we discuss how this breakthrough will advance the field of precision medicine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available